Zolgensma Kit
Product Images NDC 71894-120

Product Visual Gallery

This gallery contains 40 technical images submitted to the FDA as part of the official labeling for Zolgensma (NDC 71894-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Innovative Technologies Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel Ndc 71894-110-01 Onasemnogene Abeparvovec-xioi Zolgensma® Rx Only Suspension For Intravenous Infusion. See Enclosed Prescribing Information For Dosage And Directions For Use. Manufactured By Novartis Gene Therapies, Inc. Bannockburn, Il 60015. Us License No: 2250 5.5 mL Novartis (Zolgensma 01)

Zolgensma (onasemnogene abeparvovec-xioi) suspension for intravenous infusion in a 5.5 mL kit. The label indicates it is a prescription drug manufactured by Novartis Gene Therapies, Inc. It includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F) and warnings not to shake or freeze the product.*

FDA Label Image

Principal Display Panel Ndc 71894-115-01 Onasemnogene Abeparvovec-xioi Zolgensma® Rx Only Suspension For Intravenous Infusion. See Enclosed Prescribing Information For Dosage And Directions For Use. Manufactured By Novartis Gene Therapies, Inc. Bannockburn, Il 60015. Us License No: 2250 8.3 mL Novartis (Zolgensma 02)

Zolgensma (onasemnogene abeparvovec-xioi) kit label for intravenous infusion suspension. The label specifies storage requirements at 2°C to 8°C (36°F to 46°F) and advises not to shake or freeze. The volume is noted as 8.3 mL, manufactured by Novartis Gene Therapies, Inc.*

FDA Label Image

Principal Display Panel Onasemnogene Abeparvovec-xioi Zolgensma® Rx Only Suspension For Intravenous Infusion. Novartis Manufactured By Novartis Gene Therapies, Inc. Bannockburn, Il 60015. Us License No: 2250 Us License No: 2250 ©2021 Novartis Gene Therapies, Inc. (Zolgensma 03)

Packaging label for Zolgensma, a kit dosage form containing onasemnogene abeparvovec-xioi for intravenous infusion. The label includes storage instructions to refrigerate between 2°C to 8°C (36°F to 46°F), warnings not to shake or refreeze, and specifies the vector genomes concentration as 2.0 x 10^13 vector genomes/mL. Manufactured by Novartis Innovative Technologies Inc.*

FDA Label Image

2.6 (3.0 kg Kit Variable Label)

Packaging label for Zolgensma kit containing onasemnogene abeparvovec-xioi. The label includes patient weight range 2.6 to 3.0 kg and kit contents of two 8.3 mL vials plus two alcohol wipes. The label further displays NDC 71894-120-02, barcode, and a QR code. The product is labeled by Novartis Innovative Technologies Inc.*

FDA Label Image

3.1 (3.5 kg Kit Variable Label)

Label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc., NDC 71894-121-03. The label lists patient weight (3.1 to 3.5 kg) and kit contents: two 5.5 mL vials, one 8.3 mL vial, and three alcohol wipes. Includes barcode and a 2D matrix code along with fields for date of receipt, GTIN, serial number, expiration date, and lot number.*

FDA Label Image

3.6 (4.0 kg Kit Variable Label)

Zolgensma kit packaging label displaying the generic name onasemnogene abeparvovec-xioi. The label indicates patient weight range 3.6–4.0 kg and kit contents including one 5.5 mL vial, two 8.3 mL vials, and three alcohol wipes. Barcode and NDC number 71894-122-03 are visible along with placeholders for GTIN, serial number, expiration date, and lot number.*

FDA Label Image

4.1 (4.5 kg Kit Variable Label)

Label for Zolgensma, containing onasemnogene abeparvovec-xioi in kit form. The label states patient weight from 4.1 to 4.5 kg and kit contents of three 8.3 mL vials plus three alcohol wipes. It shows the NDC 71894-123-03, the labeler Novartis Innovative Technologies Inc., and includes barcode and QR code areas along with placeholders for GTIN, serial number, expiration date, and lot number.*

FDA Label Image

4.6 (5.0 kg Kit Variable Label)

Label for Zolgensma kit containing onasemnogene abeparvovec-xioi, intended for patients weighing 4.6 to 5.0 kg. Kit includes two 5.5 mL vials, two 8.3 mL vials, and four alcohol wipes. Label features NDC 71894-124-04, barcode, and QR code. Manufactured by Novartis Innovative Technologies Inc.*

FDA Label Image

5.1 (5.5 kg Kit Variable Label)

Label for Zolgensma kit containing onasemnogene abeparvovec-xioi, for patients weighing 5.1 to 5.5 kg. Kit includes one 5.5 mL vial, three 8.3 mL vials, and four alcohol wipes. Label shows NDC 71894-125-04, barcode, and space for date of receipt, GTIN, serial number, expiration date, and lot number. Labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

5.6 (6.0 kg Kit Variable Label)

Packaging label for Zolgensma (onasemnogene abeparvovec-xioi) kit, showing patient weight range 5.6 to 6.0 kg. Kit contents include four 8.3 mL vials and four alcohol wipes. Label includes NDC 71894-126-04, barcode, and placeholders for Date of Receipt, GTIN, SN, EXP, and LOT information. Labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

6.1 (6.5 kg Kit Variable Label)

Packaging label for Zolgensma kit containing onasemnogene abeparvovec-xioi. The label specifies patient weight range 6.1 to 6.5 kg, kit contents including two 5.5 mL vials, three 8.3 mL vials, and five alcohol wipes. The NDC number 71894-127-05 and labeler Novartis Innovative Technologies Inc. are displayed.*

FDA Label Image

6.6 (7.0 kg Kit Variable Label)

Label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc. The label specifies patient weight of 6.6 to 7.0 kg and kit contents including one 5.5 mL vial, four 8.3 mL vials, and five alcohol wipes. The NDC number 71894-128-05 is visible along with barcode and data matrix codes.*

FDA Label Image

7.1 (7.5 kg Kit Variable Label)

Zolgensma (onasemnogene abeparvovec-xioi) kit label showing patient weight range of 7.1 to 7.5 kg, containing five 8.3 mL vials and five alcohol wipes. The label includes the NDC number 71894-129-05, a barcode, a QR code, and fields for Date of Receipt, GTIN, SN, EXP, and LOT information. The kit is labeled by Novartis Innovative Technologies Inc.*

FDA Label Image

7.6 (8.0 kg Kit Variable Label)

Label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc. for patients weighing 7.6 to 8.0 kg. The kit includes 5.5 mL vials (2), 8.3 mL vials (4), and 6 alcohol wipes. The label shows the NDC 71894-130-06, barcode, QR code, and spaces for date of receipt and product identifiers like GTIN, expiration date, serial number, and lot number.*

FDA Label Image

8.1 (8.5 kg Kit Variable Label)

Label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc. The label includes the NDC number 71894-131-06, patient weight range 8.1 to 8.5 kg, and kit contents: one 5.5 mL vial, five 8.3 mL vials, and six alcohol wipes. Also shows a barcode and QR code area with receipt date fields.*

FDA Label Image

8.6 – 9.0 Kg Kit Variable Label (Zolgensma 16)

Label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc. The label indicates kit contents include six 8.3 mL vials and six alcohol wipes. It specifies a patient weight range of 8.6 to 9.0 kg and displays the NDC 71894-132-06. Additional fields for GTIN, SN, EXP, and LOT are present but not filled.*

FDA Label Image

9.1 – 9.5 Kg Kit Variable Label (Zolgensma 17)

Zolgensma kit label showing the proprietary name, onasemnogene abeparvovec-xioi as the generic name, and NDC 71894-133-07. The label includes patient weight range 9.1–9.5 kg, kit contents specifying 5.5 mL vials x 2, 8.3 mL vials x 5, and 7 alcohol wipes. Labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

9.6 – 10.0 Kg Kit Variable Label (Zolgensma 18)

Label of Zolgensma kit containing onasemnogene abeparvovec-xioi by Novartis Innovative Technologies Inc. The label includes NDC 71894-134-07, patient weight range 9.6 to 10.0 kg, and kit contents listing a 5.5 mL vial, six 8.3 mL vials, and seven alcohol wipes. It also displays a barcode, a data matrix 2D code, and placeholders for date of receipt, GTIN, SN, EXP, and LOT information.*

FDA Label Image

10.1 – 10.5 Kg Kit Variable Label (Zolgensma 19)

Zolgensma (onasemnogene abeparvovec-xioi) kit label showing NDC 71894-135-07. The label indicates a patient weight range of 10.1 to 10.5 kg. Kit contents include an 8.3 mL vial (7 vials) and 7 alcohol wipes. The label also features a barcode, a data matrix code, and placeholders for Date of Receipt, GTIN, SN, EXP, and LOT information. The labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

10.6 – 11.0 Kg Kit Variable Label (Zolgensma 20)

Packaging label for Zolgensma kit containing onasemnogene abeparvovec-xioi. The label specifies patient weight range 10.6 to 11.0 kg and lists kit contents as 5.5 mL vial x 2, 8.3 mL vial x 6, and 8 alcohol wipes. It includes the NDC number 71894-136-08 and details fields for GTIN, SN, EXP, and LOT. A barcode and a QR code are also visible on the label.*

FDA Label Image

11.1 – 11.5 Kg Kit Variable Label (Zolgensma 21)

Label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc. The label shows patient weight range 11.1–11.5 kg, kit contents including one 5.5 mL vial, seven 8.3 mL vials, and eight alcohol wipes. Includes NDC 71894-137-08, a barcode, and a data matrix code.*

FDA Label Image

11.6 – 12.0 Kg Kit Variable Label (Zolgensma 22)

Label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc., displaying patient weight range 11.6 to 12.0 kg, kit contents including eight 8.3 mL vials and eight alcohol wipes, an NDC number 71894-138-08, barcode, and a QR code. Fields for date of receipt and other batch details are present but blank.*

FDA Label Image

12.1 – 12.5 Kg Kit Variable Label (Zolgensma 23)

Packaging label for Zolgensma (onasemnogene abeparvovec-xioi) KIT by Novartis Innovative Technologies Inc., showing patient weight range of 12.1 to 12.5 kg. Kit contents listed include 5.5 mL vials (2), 8.3 mL vials (7), and 9 alcohol wipes. The label includes a barcode, NDC 71894-139-09, lot and expiration fields, and a Data Matrix code.*

FDA Label Image

12.6 – 13.0 Kg Kit Variable Label (Zolgensma 24)

Packaging label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc. The label includes patient weight range 12.6-13.0 kg and kit contents listing a 5.5 mL vial, eight 8.3 mL vials, and nine alcohol wipes. It also features barcode, NDC 71894-140-09, and placeholders for batch information.*

FDA Label Image

13.1 – 13.5 Kg Kit Variable Label (Zolgensma 25)

Zolgensma label for onasemnogene abeparvovec-xioi kit by Novartis Innovative Technologies Inc. The label indicates patient weight (13.1-13.5 kg), kit contents of nine 8.3 mL vials, and nine alcohol wipes. It also shows the NDC 71894-141-09 and contains barcode and data matrix symbols.*

FDA Label Image

13.6 – 14.0 Kg Kit Variable Label (Zolgensma 26)

Label for Zolgensma (onasemnogene abeparvovec-xioi) KIT by Novartis Innovative Technologies Inc. Indicates patient weight range 13.6 to 14.0 kg. Kit contents include 5.5 mL vial x 2, 0.3 mL vial x 8, and 10 alcohol wipes. Displays NDC 71894-142-10, barcode, GTIN, serial number, expiration date 02 AUG 2023, and lot number 610846.*

FDA Label Image

14.1 – 14.5 Kg Kit Variable Label (Zolgensma 27)

Label of Zolgensma kit containing onasemnogene abeparvovec-xioi with NDC 71894-143-10, marketed by Novartis Innovative Technologies Inc. The label lists patient weight range (14.1 – 14.5 kg) and kit contents including 5.5 mL and 8.3 mL vials, plus 10 alcohol wipes. It also shows GTIN, serial number, expiration date (02AUG2023), and lot number.*

FDA Label Image

14.6 – 15.0 Kg Kit Variable Label (Zolgensma 28)

Packaging label of Zolgensma kit containing onasemnogene abeparvovec-xioi. The label includes patient weight range (14.6-15.0 kg), kit contents (10 vials of 0.3 mL each and 10 alcohol wipes), NDC 71894-144-10, GTIN, SN, expiration date 02 August 2023, and lot number 610848. Labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

15.1 – 15.5 Kg Kit Variable Label (Zolgensma 29)

Packaging label for Zolgensma (onasemnogene abeparvovec-xioi) kit from Novartis Innovative Technologies Inc. The label indicates patient weight range, kit contents including 5.5 mL vials and 8.3 mL vials, and 11 alcohol wipes. It also shows the NDC 71894-145-11, along with GTIN, serial number, expiration date, and lot number details.*

FDA Label Image

15.6 – 16.0 Kg Kit Variable Label (Zolgensma 30)

Packaging label for Zolgensma kit containing onasemnogene abeparvovec-xioi. The label includes patient weight range (15.6-16.0 kg), kit contents listing a 5.5 mL vial, an 8.3 mL vial, and 11 alcohol wipes. The labeler is Novartis Innovative Technologies Inc. Additional details include NDC 71894-146-11, GTIN, serial number, expiration date (August 2, 2023), and lot number.*

FDA Label Image

16.1 – 16.5 Kg Kit Variable Label (Zolgensma 31)

Packaging label of Zolgensma (onasemnogene abeparvovec-xioi) KIT by Novartis Innovative Technologies Inc. It includes patient weight range (16.1–16.5 kg), kit contents listing one 6.3 mL vial and 11 alcohol wipes, the proprietary name ZOLGENSMA, and the NDC number 71894-147-11. Additional printed information includes GTIN, serial number, expiration date August 2, 2023, and lot number 010851.*

FDA Label Image

16.6 – 17.0 Kg Kit Variable Label (Zolgensma 32)

Packaging label for Zolgensma kit containing onasemnogene abeparvovec-xioi. The kit includes 3.5 mL vials and 0.3 mL vials along with alcohol wipes, with patient weight range 16.5 to 17.0 kg. Labeler is Novartis Innovative Technologies Inc., with NDC 71894-148-12 and visible GTIN, serial number, expiration date, and lot number details.*

FDA Label Image

17.1 – 17.5 Kg Kit Variable Label (Zolgensma 33)

Zolgensma kit label showing onasemnogene abeparvovec-xioi as the active ingredient. The label includes patient weight range (17.1 to 17.5 kg), kit contents including 0.5 mL vial and 0.3 mL vials, and 12 alcohol wipes. It is labeled by Novartis Innovative Technologies Inc. The label displays NDC 71894-149-12, GTIN, serial number, expiration date 02AUG2023, and lot number 610853.*

FDA Label Image

17.6 – 18.0 Kg Kit Variable Label (Zolgensma 34)

Packaging label for Zolgensma (onasemnogene abeparvovec-xioi) kit by Novartis Innovative Technologies Inc. The label shows kit contents including twelve 8.3 mL vials and twelve alcohol wipes for patient weight 17.6 to 18.0 kg. It includes NDC 71894-150-12, barcode, GTIN, serial number, expiration date (02 AUG 2023), and lot number.*

FDA Label Image

18.1 – 18.5 Kg Kit Variable Label (Zolgensma 35)

Zolgensma (onasemnogene abeparvovec-xioi) packaging label from Novartis Innovative Technologies Inc. The kit includes vial sizes of 5.5 mL and 8.3 mL with a total of 13 Alcohol Wipes. Patient weight range indicated is 18.1 to 18.5 kg. Label features the NDC 71894-151-13, GTIN, serial number, expiration date (02AUG2023), and lot number.*

FDA Label Image

18.6 – 19.0 Kg Kit Variable Label (Zolgensma 36)

Label for Zolgensma kit containing onasemnogene abeparvovec-xioi, a human prescription drug by Novartis Innovative Technologies Inc. It includes vial quantities and sizes: one 5.5 mL vial, twelve 8.3 mL vials, and 13 alcohol wipes. The label also shows patient weight range, product NDC 71894-152-13, and expiration information.*

FDA Label Image

19.1 – 19.5 Kg Kit Variable Label (Zolgensma 37)

Label from Zolgensma kit containing onasemnogene abeparvovec-xioi. The label specifies patient weight range of 19.1 to 19.5 kg, kit contents including 8.3 mL vials (13 count) and 13 alcohol wipes, with identification numbers including NDC 71894-153-13, GTIN, serial number, expiration date (02AUG2023), and lot number. Labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

19.6 – 20.0 Kg Kit Variable Label (Zolgensma 38)

Zolgensma injection kit label showing the generic name onasemnogene abeparvovec-xioi. The label includes patient weight range, kit contents listing vials and alcohol wipes, and identifiers such as GTIN, serial number, expiration date of 02 AUG 2023, and lot number. The labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

20.1 – 20.5 Kg Kit Variable Label (Zolgensma 39)

Zolgensma kit label for onasemnogene abeparvovec-xioi indicating patient weight between 20.1 and 20.5 kg. Kit contents include one 5.5 mL vial, thirteen 8.3 mL vials, and fourteen alcohol wipes. The label also displays NDC 71894-155-14, GTIN, serial number, expiration date (02AUG2023), and lot number (610859). Labeler is Novartis Innovative Technologies Inc.*

FDA Label Image

20.6 – 21.0 Kg Kit Variable Label (Zolgensma 40)

Label for Zolgensma kit containing onasemnogene abeparvovec-xioi. The label includes patient weight range (20.6 to 21.0 kg) and kit contents: fourteen 8.3 mL vials and fourteen alcohol wipes. It shows the NDC number 71894-156-14, GTIN, serial number, expiration date (August 2, 2023), and lot number. Labeler is Novartis Innovative Technologies Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.